不惜一切代价要个孩子?探索使用和提供未经证实的辅助治疗在体外受精的背景下。

IF 1.9 3区 医学 Q3 OBSTETRICS & GYNECOLOGY
Seminars in reproductive medicine Pub Date : 2021-11-01 Epub Date: 2021-09-09 DOI:10.1055/s-0041-1731789
Georgina L Jones, Victoria Lang, Nicky Hudson
{"title":"不惜一切代价要个孩子?探索使用和提供未经证实的辅助治疗在体外受精的背景下。","authors":"Georgina L Jones,&nbsp;Victoria Lang,&nbsp;Nicky Hudson","doi":"10.1055/s-0041-1731789","DOIUrl":null,"url":null,"abstract":"<p><p>The year 2018 marked 40 years since the birth of Louise Brown, the first baby born as a result of pioneering in vitro fertilization (IVF) treatment. Since then, advances have seen a wide range of reproductive technologies emerge into clinical practice, including adjuvant treatments often referred to as IVF \"add-ons.\" However, these \"optional extras\" have faced growing criticism, especially when they have often come at additional financial cost to the patient and have little evidence supporting their efficacy to improve pregnancy or birth rates. Despite this, according to the latest national patient survey by the Human Fertilisation and Embryology Authority, three quarters of patients who had fertility treatment in the United Kingdom in the past two years had at least one type of treatment add-on highlighting the growing demand for these interventions. This article uses a psychosocial perspective to consider the motivations behind patient and clinician behavior along with the wider societal and economic factors that may be impacting upon the increase in the use of adjuvant treatments in fertility clinics more widely. It suggests the reasons fertility patients use unproven \"optional extras\" are complex, with interpersonal, psychological, and social factors intertwining to generate an increase in the use of IVF add-ons.</p>","PeriodicalId":21661,"journal":{"name":"Seminars in reproductive medicine","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Baby at All Costs? Exploring the Use and Provision of Unproven Adjuvant Treatments in the Context of IVF.\",\"authors\":\"Georgina L Jones,&nbsp;Victoria Lang,&nbsp;Nicky Hudson\",\"doi\":\"10.1055/s-0041-1731789\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The year 2018 marked 40 years since the birth of Louise Brown, the first baby born as a result of pioneering in vitro fertilization (IVF) treatment. Since then, advances have seen a wide range of reproductive technologies emerge into clinical practice, including adjuvant treatments often referred to as IVF \\\"add-ons.\\\" However, these \\\"optional extras\\\" have faced growing criticism, especially when they have often come at additional financial cost to the patient and have little evidence supporting their efficacy to improve pregnancy or birth rates. Despite this, according to the latest national patient survey by the Human Fertilisation and Embryology Authority, three quarters of patients who had fertility treatment in the United Kingdom in the past two years had at least one type of treatment add-on highlighting the growing demand for these interventions. This article uses a psychosocial perspective to consider the motivations behind patient and clinician behavior along with the wider societal and economic factors that may be impacting upon the increase in the use of adjuvant treatments in fertility clinics more widely. It suggests the reasons fertility patients use unproven \\\"optional extras\\\" are complex, with interpersonal, psychological, and social factors intertwining to generate an increase in the use of IVF add-ons.</p>\",\"PeriodicalId\":21661,\"journal\":{\"name\":\"Seminars in reproductive medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in reproductive medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0041-1731789\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/9/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in reproductive medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/s-0041-1731789","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

2018年是路易丝·布朗出生40周年,她是第一个通过开创性的体外受精(IVF)治疗而出生的婴儿。从那时起,各种生殖技术进入临床实践,包括辅助治疗,通常被称为体外受精“附加组件”。然而,这些“可选择的额外服务”面临着越来越多的批评,特别是当它们往往给患者带来额外的经济成本,并且几乎没有证据支持它们对提高怀孕率或出生率的有效性时。尽管如此,根据人类受精和胚胎学管理局最新的全国患者调查,在过去两年中,在英国接受生育治疗的患者中,有四分之三至少有一种附加治疗,这突显了对这些干预措施日益增长的需求。本文从社会心理角度考虑患者和临床医生行为背后的动机,以及更广泛的社会和经济因素,这些因素可能会影响生育诊所更广泛地使用辅助治疗。研究表明,不孕患者使用未经证实的“可选择的附加功能”的原因是复杂的,人际、心理和社会因素交织在一起,导致体外受精附加功能的使用增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Baby at All Costs? Exploring the Use and Provision of Unproven Adjuvant Treatments in the Context of IVF.

The year 2018 marked 40 years since the birth of Louise Brown, the first baby born as a result of pioneering in vitro fertilization (IVF) treatment. Since then, advances have seen a wide range of reproductive technologies emerge into clinical practice, including adjuvant treatments often referred to as IVF "add-ons." However, these "optional extras" have faced growing criticism, especially when they have often come at additional financial cost to the patient and have little evidence supporting their efficacy to improve pregnancy or birth rates. Despite this, according to the latest national patient survey by the Human Fertilisation and Embryology Authority, three quarters of patients who had fertility treatment in the United Kingdom in the past two years had at least one type of treatment add-on highlighting the growing demand for these interventions. This article uses a psychosocial perspective to consider the motivations behind patient and clinician behavior along with the wider societal and economic factors that may be impacting upon the increase in the use of adjuvant treatments in fertility clinics more widely. It suggests the reasons fertility patients use unproven "optional extras" are complex, with interpersonal, psychological, and social factors intertwining to generate an increase in the use of IVF add-ons.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Seminars in reproductive medicine
Seminars in reproductive medicine 医学-妇产科学
CiteScore
5.80
自引率
0.00%
发文量
24
审稿时长
6-12 weeks
期刊介绍: Seminars in Reproductive Medicine is a bi-monthly topic driven review journal that provides in-depth coverage of important advances in the understanding of normal and disordered human reproductive function, as well as new diagnostic and interventional techniques. Seminars in Reproductive Medicine offers an informed perspective on issues like male and female infertility, reproductive physiology, pharmacological hormonal manipulation, and state-of-the-art assisted reproductive technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信